SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-20-014311
Filing Date
2020-06-08
Accepted
2020-06-05 20:51:22
Documents
1
Effectiveness Date
2020-06-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea122767-defa14a_delmarphar.htm DEFA14A 27776
  Complete submission text file 0001213900-20-014311.txt   28872
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-37823 | Film No.: 20947914
SIC: 2834 Pharmaceutical Preparations